Abstract: Fetal alcohol syndrome (FAS) is a developmental neuropathology resulting from in utero exposure to ethanol; many of ethanol's effects are likely to be mediated by the neurotransmitter γ-aminobutyric acid (GABA). We studied modulation of the neurotransmitter receptor GABA B R and its capacity for intracellular signal transduction under conditions of ethanol treatment (ET) and RNA interference to investigate a potential role for GABA signaling in FAS. ET increased GABA B1 R protein levels, but decreased protein kinase A-α (PKA-α), calcium/calmodulin-dependent protein kinase II (CaMKII) and phosphorylation of cAMP-response element binding protein (p-CREB), in cultured hippocampal neurons harvested at gestation day 17.5. To elucidate GABA B1 R response to ethanol, we observed the effects of a GABA B R agonist and antagonist in pharmacotherapy for ethanol abuse. Baclofen increased GABA B R, CaMKII and p-CREB levels, whereas phaclofen decreased GABA B R, CaMKII and p-CREB levels except PKA-α. Furthermore, when GABA B1 R was knocked down by siRNA treatment, CaMKII and p-CREB levels were reduced upon ET. We speculate that stimulation of GABA B1 R activity by ET can modulate CaMKII and p-CREB signaling to detrimental effect on fetal brain development.
Introduction
Exposure to ethanol during gestation induces abnormalities of structure and function on neuronal maturation, resulting in fetal alcohol syndrome (FAS) in the brain [1] [2] [3] [4] . FAS is a specific, recognizable pattern of malformation, resulting from exposure of the human fetus to ethanol and in the mammalian CNS, has been less well characterized due to the limited number of pharmacologic agents that can interact with GABA B R [11] , which mediates slow inhibitory GABA synaptic neurotransmission through association with G proteins and through cAMP-dependent signaling [12, 13] . Some studies have indicated that the GABA B R agonist baclofen can reduce ethanol intake, although this may depend on the dose administered [14] [15] [16] [17] . In addition, the GABA B R antagonist phaclofen attenuates the coordinating and locomotor-activating effects produced by low doses of ethanol. Moreover, phaclofen reduces some of the behavioral alterations produced by anesthetic concentrations of ethanol [18] . RNA interference (RNAi) against the GABA B1 R or treatment with the GABA B antagonist CGP 54626 reduces ethanol's impairment of behavior, possibly implying a role for GABA B R in mediating ethanol's neurological effects [19] . Furthermore, the cAMP-signaling pathway is a major target of ethanol in the CNS [20] . It has been previously reported that the activation of protein kinase A (PKA) is likely to be responsible for cAMP response element binding protein (CREB) phosphorylation, and in the hippocampus, stimulation of adenylyl cyclase either by Ca 2+ /calmodulin kinase (CaMKII) or by receptor-coupled G proteins increases intracellular concentrations of cAMP. Thus, the GABA B system may transduce ethanol's effects [11] .
In the present study, we used an agonist and an antagonist of GABA B R, as well as siRNA treatment, to study the mo dulation of GABA B1 R, PKA-α, CaMKII, and p-CREB ex pression in cultivated hippocampal neurons in vitro under ethanol treatment (ET).
Materials and Methods

Animal treatment
Female (n=30) Sparague-Dawley rats (250 g, Gyeongsang National University Neurobiology Laboratory, Jinju, Korea) were housed in a temperature-controlled environment with lights on from 6:00-20:00 h and food ad libitum. Pregnant rats were killed by ethyl ether anesthesia at gestational day (GD) 17.5 of fetal development.
Primary hippocampal cell culture
Primary hippocampal cultures were prepared from brains of GD 17.5 fetuses. Hippocampal tissues were treated with 0.25% trypsin-EDTA for 20 
Reverse transcription polymerase chain reaction (RT-PCR)
RT-PCR analysis was performed to identify cDNAs transcribed in transfected or mock-transfected cultures. Total RNA was isolated with TRIzol Reagent (Life Technologies, Rockville, MD, USA). First strand cDNA was transcribed from 2 µg RNA using oligo (dT) 15 and M-MLV reverse transcriptase (Promega, Madison, WI, USA) according to manufacturer's instructions. A total of 4 µl cDNA were used for PCR amplification with 1 µl Taq DNA polymerase. Thermal cycling was performed under the following conditions: 94°C for 5 minutes; 30 cycles at 94°C, 68°C, and 72°C for 1 minute each; final extension at 72°C for 5 minutes. A negative control PCR for β-actin was performed at 58°C for 25 cycles. PCR product was run out on a 1% agarose gel containing ethidium bromide and viewed under UV light. The primers used were the following:
GABA B1 R forward primer: 5'-AATTGAATTCCGCTACC ATCCAACAGACCA-3'; GABA B1 R reverse primer: 5'-AATTAAGCTTTCCTGTG ACGTCATGTTGGAA-3'
Western blotting
Drug-treated hippocampal cells were homogenized in cell lysis buffer (Cell Signaling no. 9803, Danvers, MA, USA) for protein extraction. After two rounds of ultra-centrifugation at 12,000 rpm for 10 minutes (4°C), supernatant protein concentration was quantified using the Bio-Rad protein assay kit. Thirty µg soluble fraction were separated on duplicate 12% sodium dodecyl sulfate (SDS)-polyacrylamide gels (30% acrylamide, 1% Bis, 1 M Tris, 20% SDS, 10% APS, TEMED). Proteins were transferred to polyvinylidene fluoride membrane at 90 V for 1 hour (in electrotransfer buffer with 48 mM Tris, 39 mM glycine, 20% MeOH, and 0.037% SDS). Membranes were treated with blocking solution (Tris-buffered saline containing 0.1% [v/v] Tween-20 and 6% [w/v] non-fat dry milk) to reduce non-specific binding. Immunostaining was carried out using a guinea-pig derived anti-rat GABA B1 R (1 : 500, 24 hours, 4°C, Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-rat PKA-α (1 : 500, Santa Cruz Biotechnology), rabbit anti-rat CaMKII (1 : 500, Cell Signaling) or rabbit anti-rat p-CREB (1 : 500, Cell Signaling). Anti-Actin antibody (1 : 1,000, Sigma-Aldrich, Jerusalem, Israel) was taken as control to confirm uniform loading. Anti gen was detected by enhanced chemiluminescence (Western blotting detection reagents, Amersham Pharmacia Biotech, Piscataway, NJ, USA) according to manufacturer's instructions. In some cases, the blots were stripped and re probed. Briefly, after film exposure, washed membrane four times for 5 minutes each in TBST, then agitated gently the membrane in the antibody stripping solution (ReBlot Plus Strong Antibody stripping solution, Millipore, Temecula, CA, USA) at room temperature for 15 minutes. After that, again washed the membrane four times for minutes each in TBST, then reprobed with a rabbit antiactin (1 : 1,000, Sigma-Aldrich). Western blots were analyzed by densitometry using the computer-based Sigma Gel system (SPSS Inc., Chicago, IL, USA). Density values were expressed as mean±SEM. A Student's t-test was performed to determine significant differences among groups. In each case, significance was accepted to be P<0.05.
Immunofluorescence assays
Immunofluorescence was performed on GD 17.5 primary hippocampal cell cultures grown in vitro on poly-L-lysine coated round glass coverslips. Cultures were fixed for 5 minutes with 4% paraformaldehyde in phosphate buffered saline (PBS), permeabilized in 0.3% Triton X-100 in PBS for 5 minutes, and rinsed twice in PBS. The cells were preincubated with 10% bovine seum albumin in PBS for 1 hour at 37°C before exposure to primary antibodies overnight at 4°C. Immunostaining was carried out using guinea-pig derived anti-rat GABA B1 R antibody (1 : 500, 24 hours, 4°C, Santa Cruz Biotechnology), rabbit anti-rat PKA-α antibody (1 : 500, Santa Cruz Biotechnology), or rabbit anti-rat anti-p-CREB antibody (1 : 500, Cell Signaling). Following incubation, cells were washed and secondary antibodies applied as follows: anti-rabbit IgG-TRITC and -FITC conjugated antibodies, 1 : 100; anti-guinea pig IgG-FITC conjugate, 1 : 150 (both from DAKOCytomation, Glostrup, Denmark). For co-staining, incubations were performed in parallel. Glass cover-slips were affixed to slides with mounting medium. Imaging was performed with a fluorescence microscope (Zeiss, Jena, Germany) or confocal microscope (Olympus, Tokyo, Japan), and images captured with a soft imaging systems video camera.
Results
Alterations in GABA B1 R mRNA expression con comitant with ET and siRNA transfection
To investigate whether ethanol can modulate GABA B1 R expression, we observed the changes in GABA B1 R expression
www.acbjournal.org levels induced by ET on cultured GD 17.5 rat hippocampal neurons. GABA B1 R mRNA levels were decreased by ET, but increased by baclofen treatment (BT) or phaclofen treatment (PT). Transfection of siRNA complementary to endogenous GABA B1 R mRNA led to its efficient destruction, while β-actin levels were unchanged (Fig. 1) .
Alterations in protein expression of GABA B1 R, PKA-α, CaMKII and p-CREB concomitant with ET and siRNA transfection
We wished to ascertain whether ET-mediated transcriptional alterations affected protein levels in cultured GD 17.5 rat hippocampal neurons. Western blotting results showed that GABA B1 R protein levels were increased by ET in vitro, but this effect was reversed by PT. BT potentiated the effect of ethanol on GABA B1 R expression (Fig. 2) . In contrast, no remarkable change in PKA-α level was observed under ET or PT in vitro (Fig. 3) . Because PKA-α levels were unchanged upon GABA B1 R knockdown, as well as BT and PT, we speculated that CaMKII might instead regulate p-CREB. Ethanol decreased CaMKII expression in GD 17.5 rat hippocampal neurons, whereas BT, PT, and baclofen plus phaclofen treatment (BPT) reversed these effects; BT, PT, and BPT significantly decreased CaMKII expression upon siRNA knockdown of GABA B1 R (Fig. 4) . p-CREB protein levels were decreased by ET, an effect reversed by BT, PT did not alter protein expression. We additionally probed whether ethanol-induced changes in GABA B1 R expression affected its intracellular signal transduction, knocking down its expression by RNAi to that end. GABA B1 R knockdown reduced all of p-CREB expression level (Fig. 5) . The density values on (Y-axis) were expressed as arbitrary units (AU). N, normal media as control; E, treated with 100 mM ethanol; B, 50 mM baclofen; P, 100 mM phaclofen; BP, 50 μM baclofen plus 100 mM phaclofen. With GABA B1 R siRNA transfection: TN, normal media as control; TE, 100 mM ethanol; TB, 50 mM baclofen; TP, 100 mM phaclofen; TBP, 50 mM baclofen plus 100 mM phaclofen; GABA, γ-aminobutyric acid. *P<0.05 in nontransfected group. 
Co-localization of GABA B1 R, p-CREB, and changes in distribution with siRNA transfection
To confirm the localization of GABA B1 R and p-CREB, and to determine changes mediated by siRNA knockdown of GABA B1 R, we performed immunofluorescence assays on GD 17.5 rat hippocampal neurons. GABA B1 R co-localized with p-CREB in hippocampal neuronal cytoplasm and p-CREB distribution was reduced by GABA B1 R siRNA (Fig. 6) .
Together, these results demonstrate that ethanol can modulate phosphorylation of CREB via PKA-α or CaMKII pathway intracellular Ca 2+ dependently, which is linked to GABA B1 R activation in prenatal hippocampal neurons (Fig. 7) .
Discussion
In this study, we have endeavored to characterize alterations to GABA B R, PKA-α, and p-CREB expression in response to ET in cultured hippocampal neurons. We have ad ditionally tested the modulatory effects of a GABA B1 R agonist and/or antagonist on ET-mediated GABA-ergic signaling, as well as that of GABA B1 R gene knockdown. We find that ethanol regulates GABA B R expression disparately at mRNA and protein levels, suggesting that these effects are not completely attributable to changes in gene expression as previously mentioned [21] . Ethanol increased GABA B1 R protein expression, but decreased that of PKA-α and p-CREB, in our study. Previous research has demonstrated that ET reduces hippocampal p-CREB protein levels in a manner reversible upon its withdrawal [22] ; however, there is some contention over these findings, as other work has found that chronic ethanol . N, normal media as control; E, treated with 100 mM ethanol; B, 50 μM baclofen; P, 100 mM phaclofen; With GABA B1 R siRNA transfection: TN, normal media as control; TE, 100 mM ethanol; TB, 50 mM baclofen; TP, 100 mM phaclofen; GABA, γ-aminobutyric acid. *P<0.05 in nontransfected group, † P<0.05 in transfected group. . N, normal media as control; E, treated with 100 mM ethanol; B, 50 μM baclofen; P, 100 mM phaclofen; BP, 50 μM baclofen plus 100 mM phaclofen. With GABA B1 R siRNA transfection: TN, normal media as control; TE, 100 mM ethanol; TB, 50 mM baclofen; TP, 100 mM phaclofen; TBP, 50 mM baclofen plus 100 mM phaclofen; GABA, γ-aminobutyric acid. *P<0.05 in nontransfected group, † P<0.05 in transfected group.
www.acbjournal.org treatment (CET) may decrease long-term potentiation in the hippocampus through reduction in presynaptic GABA B autoreceptor, and CET decreases GABA B R expression consistent with increased GABA release [23] . Additionally, PKA and p-CREB protein expression were significantly lower in the hippocampi of model rats experiencing chronic, unpredicted, mild stress than in normal control animals [24] , and alcohol-preferring rats that exhibit increased ethanol consumption likewise increase p-CREB expression selectively in the central amygdala after acute ET. Thus, it has been assumed that ethanol-induced reduction in GABA B1 R levels stems from tolerance to ET in vivo [25] .
We determined that p-CREB levels were decreased by ET in vitro, and that this decrease could be counteracted by BT. These findings agreed with previous reports that chronic binge ethanol administration results in neurodegeneration of the hippocampal dentate gyrus, reduced neurogenesis, decreases in p-CREB, decreased expression of pro-survival genes, and increased vulnerability to insults and neuronal death. Also, drug-induced CREB inactivation may lead to hippocampal neurotoxicity [26] . Several studies indicate that baclofen may reduce ethanol intake [14] [15] [16] [17] , and preclinical and clinical research has evaluated the potential of GABA B R subtype agonists as pharmacotherapy for substance abuse, including that of ethanol. Baclofen contributes significantly to neuroprotection against ischemia in organotypic hippocampal slices [27] . However, the detailed molecular mechanisms for modulation by ethanol of GABA B R signal transduction will require more thorough investigation.
To further confirm the modulatory effects of ET on GABA B R, we knocked down GABA B1 R expression by RNAi and examined the hippocampal responses to ethanol in vitro. The same effects were observed with BT, PT, and BPT after RNAi against GABA B1 R. GABA B suppresses neurotransmitter release via inhibition of Ca 2+ channels [28] , and our results demonstrated a similar trend upon direct ethanol exposure. Activation of presynaptic GABA B R at certain synapses can inhibit adenylyl cyclase, thereby decreasing cAMP levels and PKA activity to result in suppression of GABA release [29] [30] [31] . GABA B R stimulation also signals to effectors through the G protein βγ subunit; βγ-mediated signaling includes the activation of G protein coupled inwardly rectifying potassium channels and the inhibition of voltage-gated calcium channels [32] . Since PKA-α and CaMKII can diffuse into the nucleus and phosphorylate CREB at the same serine residue, it is possible that GABA B R and calmodulin kinase engage in crosstalk.
In conclusion, we studied alterations in GABA B1 R and intracellular signaling factor expression upon ET in cultured rat hippocampal neurons. Ethanol reduced p-CREB levels in the presence of functional GABA B1 R, but RNAi knockdown of GABA B1 R or BT treatment reversed this effect. GABA B R therefore can modulate p-CREB expression in the nucleolus through either PKA-α or CaMKII. . N, normal media as control; E, treated with 100 mM ethanol; B, 50 mM baclofen; P, 100 mM phaclofen; BP, 50 mM baclofen plus 100 mM phaclofen. With GABA B1 R siRNA transfection: TN, normal media as control; TE, 100 mM ethanol; TB, 50 mM baclofen; TP, 100 mM phaclofen; TBP, 50 mM baclofen plus 100 mM phaclofen; GABA, γ-aminobutyric acid. *P<0.05 in nontransfected group, Fig. 6 . Co-localization and intracellular distribution of GABA B1 R and p-CREB in primary cultured gestational day 17.5 hippocampal cells with and without siRNA knockdown of GABA B1 R. Immunofluorescence images reflect GABA B1 R (green) and p-CREB (red) localization in the cytoplasm and nucleus of the same neuron (arrows, nucleus; arrowheads, cytoplasm). GABA, γ-aminobutyric acid; p-CRRB, phosphorylation of cAMP-response element binding protein. Scale bars=30 mm. Fig. 7 . Schema of main intracellular signal transduction pathways affected by GABA B1 R activation. GABA B1 R cou pled with G i/o proteins inhibits PKA-α through adenylyl cyclase and CaMKII via Ca 2+ channels, leading to inactivation of p-CREB. GABA B1 R is increased by ET, but decreased by RNAi knockdown. GABA, γ-aminobutyric acid ; PKA, pro tein kinase A; CaMKII, calcium/ calmodulindependent protein kinase II; p-CREB, phosphorylation of cAMPresponse element binding protein ; ET, ethanol treatment; RNAi, RNA interference.
